World's Best Scientists 2026 revealed!
Scott H. Kaufmann

Scott H. Kaufmann

D-Index & Metrics

Biology and Biochemistry

D-Index
126
Citations
63622
World Ranking
489
National Ranking
312

Medicine

D-Index
126
Citations
63359
World Ranking
2939
National Ranking
1628

Overview

Scott H. Kaufmann is affiliated with the Mayo Clinic in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on subfields such as Molecular Biology, Oncology, Reproductive Medicine, Hematology, and Cancer Research.

The scientist's work covers a range of main topics including:

  • Ovarian cancer diagnosis and treatment
  • PARP inhibition in cancer therapy
  • DNA Repair Mechanisms
  • Acute Myeloid Leukemia Research
  • CRISPR and Genetic Engineering
  • Cell death mechanisms and regulation
  • Protein Degradation and Inhibitors

Among their recent publications are:

  • Apoptotic stress causes mtDNA release during senescence and drives the SASP, 2023, Nature
  • Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2), 2021, Nature Communications
  • Prognostic gene expression signature for high-grade serous ovarian cancer, 2020, Annals of Oncology
  • FAM111A protects replication forks from protein obstacles via its trypsin-like domain, 2020, Nature Communications
  • RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis, 2021, Nature Communications

Kaufmann's frequent co-authors include:

  • Xiaonan Hou
  • S. John Weroha
  • Cristina Correia
  • Paula A. Schneider
  • Kevin L. Peterson

The scientist regularly publishes in several venues, with most contributions appearing in:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Gynecologic Oncology
  • Blood

Best Publications

  • Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis

    William C. Earnshaw;Luis M. Martins;Scott H. Kaufmann

  • Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

    Y. A. Lazebnik;S. H. Kaufmann;S. Desnoyers;G. G. Poirier

  • Specific Proteolytic Cleavage of Poly(ADP-ribose) Polymerase: An Early Marker of Chemotherapy-induced Apoptosis

    Scott H. Kaufmann;Serge Desnoyers;Yvonne Ottaviano;Nancy E. Davidson

  • Induction of apoptosis by cancer chemotherapy.

    Scott H. Kaufmann;William C. Earnshaw

  • PARP inhibition: PARP1 and beyond

    Michèle Rouleau;Anand Patel;Michael J. Hendzel;Scott H. Kaufmann

  • Induction of Endonucleolytic DNA Cleavage in Human Acute Myelogenous Leukemia Cells by Etoposide, Camptothecin, and Other Cytotoxic Anticancer Drugs: A Cautionary Note

    Scott H. Kaufmann

  • Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

    Elizabeth M Swisher;Kevin K Lin;Amit M Oza;Clare L Scott

  • Programmed cell death: alive and well in the new millennium.

    Scott H. Kaufmann;Michael O. Hengartner

  • Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c

    M. Eugenia Guicciardi;Jan Deussing;Hideyuki Miyoshi;Steven F. Bronk

  • The Current Status of Camptothecin Analogues as Antitumor Agents

    William J. Slichenmyer;Eric K. Rowinsky;Ross C. Donehower;Scott H. Kaufmann

  • Caspases and caspase inhibitors.

    Pascal Villa;Scott H. Kaufmann;William C. Earnshaw

  • The role of proteases during apoptosis.

    Tushar Patel;Gregory J. Gores;Scott H. Kaufmann

  • Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution

    Yuri A. Lazebnik;Atsushi Takahashi;Robert D. Moir;Robert D. Goldman

  • Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas

    William A. Faubion;M. Eugenia Guicciardi;Hideyuki Miyoshi;Steven F. Bronk

  • Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis.

    Atsushi Takahashi;Emad S. Alnemri;Yuri A. Lazebnik;Yuri A. Lazebnik;Teresa Fernandes-Alnemri

  • Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

    Thomas E. Witzig;Susan M. Geyer;Irene Ghobrial;David J. Inwards

  • PICKLE is a CHD3 chromatin-remodeling factor that regulates the transition from embryonic to vegetative development in Arabidopsis

    Joe Ogas;Scott Kaufmann;Jim Henderson;Chris Somerville

  • Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

    Judith E. Karp;Jeffrey E. Lancet;Scott H. Kaufmann;David W. End

  • Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells

    Anand G. Patel;Jann N. Sarkaria;Scott H. Kaufmann

  • Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

    E K Rowinsky;L B Grochow;C B Hendricks;D S Ettinger

Frequent Co-Authors

Judith E. Karp
Judith E. Karp Johns Hopkins University
Elizabeth M. Swisher
Elizabeth M. Swisher University of Washington
Timothy Kottke
Timothy Kottke Mayo Clinic
William C. Earnshaw
William C. Earnshaw University of Edinburgh
Clare L. Scott
Clare L. Scott Walter and Eliza Hall Institute of Medical Research
Alex A. Adjei
Alex A. Adjei Cleveland Clinic
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Larry M. Karnitz
Larry M. Karnitz Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Scott H. Kaufmann

Trending Scientists